ESTRADIOL BIOSYNTHETIC PATHWAY (PW:0000781)
Description
Estrogen hormones are responsible for the development and maintenance of female phenotype and reproductive functions and a range of other processes in nonreproductive tissues. Estradiol, the main C18 estrogen, is primarily synthesized in the ovaries. Like all steroid hormones, estrogens are derived from cholesterol; their biosynthesis is tightly regulated by the hypothalamus-pituitary-gonadal axis. The chronic steroidogenic response involves the change in the expression of steroidogenic genes while the acute response involves the quick delivery of cholesterol to the site of the first enzymatic reaction. The rapid flux of cholesterol from the outer to the inner mitochondrial membrane (IMM) is mediated by the StAR protein. The IMM is the site where Cyp11a1, the enzyme catalyzing the first and rate-limiting step in the steroid biosynthetic pathway, is located. Overall there are two major classes of enzymes: the heme-containing cytochrome P450 and the hydroxysteroid dehydrogenase enzymes. The members of the P450 superfamily that participate in the pathway are membrane-bound mitochondrial or endoplasmic reticulum (microsome) enzymes that utilize NADPH as an electron donor. Two proteins mediate the mitochondrial electron transfer - the flavin containing Fdxr and the iron-sulfur Fdx1; only one protein mediates the microsomal electron transfer - the P450 (cytochrome) oxidoreductase Por with two flavin cofactors. Dehydrogenases are membrane-bound mitochondrial or microsomal enzymes that utilize NAD or NADPH depending on whether the reaction is oxidation or reduction. The 27-carbon cholesterol is converted to the C
21 pregnenolone in a series of three chemical reactions that together constitute the step catalyzed by Cyp11a1. Cyp17a1 catalyzes the conversion of pregnenolone to 17OH-pregnenolone; in a second step, 17OH-pregnenolone is cleaved at the C
17 -C
20 bond by the lyase activity of the enzyme to produce the C
19 androgen dehydroepiandrosterone (DHEA) in the zona reticularis, or inner zone of the adrenal gland cortex. Cyp17a1 can also convert the pregnenolone-derived progesterone to 17OH-progesterone which is then cleaved to C19 androstenedione. This route (not shown) is insignificant in humans but it is used by other species. DHEA can be sulfonated to DHEAS by Sult2a; the reverse reaction is carried out by steroid sulfatase Sts. DHEAS:DHEA ratio links to physiological as well as pathophysiological states. DHEA is converted to androstenediol or to androstenedione by hydroxysteroid dehydrogenase Hsd17b3, and Hsd31 or 2, respectively. Testosterone is then generated from androstenediol and androstenedione by the actions of Hsd3b1 or Hsd3b2, and Hsd17b3, respectively. Estrogens estradiol (E2) and estrone (E1) are derived from testosterone and androstenedione, respectively by Cyp19a1 (aromatase) in multistep reactions. Estrone is reduced to the more potent estradiol by Hsd17b1. Estrone can also be sulfonated by the estrogen specific sulfotransferase Sult1e1, a reaction reversed by the steroid sulfatase Sts. As in the case of testosterone oxidation to androstenedione, Hsd17b2 oxidizes and thus inactivates, estradiol to estrone.
To see the ontology report for annotations, GViewer and download click here [click to see the ontology report for related GO term -
GO:0006703 , associated KEGG map -
map00140 and related entry at Reactome -
REACT_11057.2 ]
The estradiol biosynthetic pathway is part of the Steroid Hormone Biosynthesis Pathway Suite. Click here to view the entire suite of related pathways....(less)
Pathway Diagram:
Genes in Pathway:
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
ISO
RGD
PMID:17926129
RGD:4892309
NCBI chr 8:67,318,665...67,330,196
Ensembl chr 8:67,270,556...67,330,196
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
ISO
RGD
PMID:17926129
RGD:4892309
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:255,476,861...255,482,974
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
ISO
RGD
PMID:18821018
RGD:2325883
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:63,449,148...63,476,917
G
Fdx1
ferredoxin 1
ISO
RGD
PMID:18821018
RGD:2325883
NCBI chr 8:61,164,839...61,183,645
Ensembl chr 8:61,164,839...61,183,583
G
Fdxr
ferredoxin reductase
ISO
RGD
PMID:18821018
RGD:2325883
NCBI chr10:101,006,845...101,015,582
Ensembl chr10:101,006,849...101,015,542
G
Hsd17b1
hydroxysteroid (17-beta) dehydrogenase 1
TAS ISO
RGD
PMID:15583024 PMID:18821018
RGD:4889549 , RGD:2325883
NCBI chr10:86,510,011...86,512,211
Ensembl chr10:86,510,011...86,512,210
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
ISO
RGD
PMID:15583024
RGD:4889549
NCBI chr19:62,662,320...62,733,944
Ensembl chr19:62,662,098...62,733,943
G
Hsd17b3
hydroxysteroid (17-beta) dehydrogenase 3
ISO
RGD
PMID:18821018
RGD:2325883
NCBI chr17:1,032,958...1,064,283
Ensembl chr17:1,032,958...1,064,283
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
ISO
RGD
PMID:15583024
RGD:4889549
NCBI chr 2:188,858,574...188,864,694
G
Hsd3b2
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
ISO
RGD
PMID:15583024
RGD:4889549
NCBI chr 2:188,784,614...188,812,535
Ensembl chr 2:188,784,614...188,790,569
G
Por
cytochrome p450 oxidoreductase
ISO
RGD
PMID:17926129
RGD:4892309
NCBI chr12:26,587,674...26,655,612
Ensembl chr12:26,587,674...26,635,809
G
Star
steroidogenic acute regulatory protein
ISO
RGD
PMID:18821018
RGD:2325883
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:72,961,518...72,974,447
G
Sts
steroid sulfatase
ISO
RGD
PMID:21693170
RGD:6893583
NCBI chr X:46,102,524...46,110,868
Ensembl chr X:46,102,548...46,111,104
G
Sult1e1
sulfotransferase family 1E member 1
ISO
RGD
PMID:21693170
RGD:6893583
NCBI chr14:20,700,444...20,718,719
Ensembl chr14:20,700,292...20,718,716
G
Sult2a1
sulfotransferase family 2A member 1
ISO
RGD
PMID:18821018
RGD:2325883
NCBI chr 1:84,582,011...84,639,001
Pathway Gene Annotations
Disease Annotations Associated with Genes in the estradiol biosynthetic pathway
Cyp11a1 46, XY Disorders of Sex Development , Adrenal Insufficiency , autism spectrum disorder , Brain Injuries , Cardiomegaly , chronic obstructive pulmonary disease , congenital adrenal hyperplasia , Congenital Adrenal Hyperplasia due to 21 Hydroxylase Deficiency , congenital adrenal insufficiency , Disorders of Environmental Origin , Endometrial Neoplasms , Experimental Diabetes Mellitus , Fetal Growth Retardation , genetic disease , hyperglycemia , hypertension , hypogonadism , Lipoid Congenital Adrenal Hyperplasia , nephrosis , sciatic neuropathy , status epilepticus , type 2 diabetes mellitus Cyp17a1 17,20-Lyase Deficiency, Isolated , amenorrhea , breast cancer , Breast Neoplasms , cholelithiasis , congenital adrenal hyperplasia , Congenital Adrenal Hyperplasia due to 21 Hydroxylase Deficiency , Congenital Adrenal Hyperplasia, Type 5 , Experimental Liver Cirrhosis , Female Infertility , gallbladder cancer , genetic disease , Genetic Predisposition to Disease , hepatocellular carcinoma , Hyperkalemia , hypogonadism , hypopituitarism , male infertility , malignant hypertension , metabolic dysfunction-associated steatotic liver disease , Neuralgia , Oligomenorrhea , osteoporosis , ovarian cyst , pancreatic cancer , polycystic ovary syndrome , primary ovarian insufficiency , prostate cancer , Prostatic Neoplasms , sciatic neuropathy , sexual health disorder , urinary bladder cancer Cyp19a1 adenocarcinoma , Alzheimer's disease , amenorrhea , aromatase excess syndrome , autism spectrum disorder , autistic disorder , bladder neck obstruction , bone resorption disease , breast cancer , Breast Neoplasms , Critical Illness , Diabetic Nephropathies , endometrial cancer , endometriosis , Esophageal Neoplasms , esophagus adenocarcinoma , Experimental Diabetes Mellitus , Female Infertility , Fibrosis , gestational diabetes , hypertension , hypogonadism , hypopituitarism , hypothyroidism , Kidney Reperfusion Injury , Knee Osteoarthritis , Neoplasm Metastasis , osteoporosis , ovarian cancer , ovarian disease , placental insufficiency , polycystic ovary syndrome , Postmenopausal Osteoporosis , prostate carcinoma in situ , Prostatic Neoplasms , prostatitis , protein-energy malnutrition , Recurrence , Reperfusion Injury , Sexual Infantilism , Sjogren's syndrome , steatotic liver disease , Tissue Adhesions , urethral obstruction , urinary bladder cancer Fdx1 pancreatitis Fdxr Arterial Occlusive Diseases , Auditory Neuropathy , fundus dystrophy , genetic disease , Multiple mitochondrial dysfunctions syndrome 9A , Multiple mitochondrial dysfunctions syndrome 9B , optic atrophy , OPTIC ATROPHY-ATAXIA-PERIPHERAL NEUROPATHY-GLOBAL DEVELOPMENTAL DELAY SYNDROME Hsd17b1 autism spectrum disorder , endometriosis , invasive ductal carcinoma , Prostatic Neoplasms , Spontaneous Abortions Hsd17b2 Endometrial Neoplasms , endometriosis , Experimental Liver Cirrhosis Hsd17b3 17-beta hydroxysteroid dehydrogenase 3 deficiency , Alzheimer's disease , disorder of sexual development , Prostatic Neoplasms , type 2 diabetes mellitus Hsd3b1 Alzheimer's disease , autism spectrum disorder , hyperprolactinemia , hypertension , hypogonadism , hypospadias , hypothyroidism , polycystic ovary syndrome , Prostatic Neoplasms , sciatic neuropathy , type 2 diabetes mellitus Hsd3b2 Adrenal Hyperplasia 2 , Alzheimer's disease , congenital adrenal hyperplasia , cryptorchidism , Ependymomas , genetic disease , hepatocellular carcinoma , hyperprolactinemia , hypertension , hypospadias , Hypospadias 1, X-Linked , Paranoid Disorders , polycystic ovary syndrome , Prostatic Neoplasms Por 46, XY Disorders of Sex Development , amenorrhea , Antley-Bixler syndrome , Antley-Bixler syndrome with disordered steroidogenesis , congenital adrenal hyperplasia , Congenital Adrenal Hyperplasia due to 21 Hydroxylase Deficiency , congestive heart failure , cytochrome P450 oxidoreductase deficiency , Desbuquois dysplasia , disorder of sexual development , Fine-Lubinsky Syndrome , genetic disease , gliosarcoma , Hirschsprung's disease , Hypotension , learning disability , Lung Injury , Musculoskeletal Abnormalities , Neoplastic Cell Transformation , neural tube defect , primary ovarian insufficiency , urinary bladder cancer Star Cardiomegaly , congenital adrenal hyperplasia , Disorders of Environmental Origin , Endometrial Neoplasms , Experimental Diabetes Mellitus , Fetal Growth Retardation , Fever , genetic disease , hypogonadism , hypothyroidism , Lipoid Congenital Adrenal Hyperplasia , nephrosis , polycystic ovary syndrome , syndactyly-telecanthus-anogenital and renal malformations syndrome , type 2 diabetes mellitus Sts alcoholic hepatitis , attention deficit hyperactivity disorder , autism spectrum disorder , COVID-19 , cryptorchidism , Experimental Diabetes Mellitus , genetic disease , hypertension , Inflammation , Insulin Resistance , obesity , rheumatoid arthritis , steatotic liver disease , Weight Gain , X-linked ichthyosis Sult1e1 alcoholic hepatitis , breast cancer , Chemical and Drug Induced Liver Injury , endometrial cancer , Experimental Liver Cirrhosis , liver disease , Neoplasm Metastasis , Prostatic Neoplasms , Reperfusion Injury Sult2a1 Experimental Liver Cirrhosis , prostate cancer , Prostatic Neoplasms
17,20-Lyase Deficiency, Isolated Cyp17a1 17-beta hydroxysteroid dehydrogenase 3 deficiency Hsd17b3 46, XY Disorders of Sex Development Cyp11a1 , Por adenocarcinoma Cyp19a1 Adrenal Hyperplasia 2 Hsd3b2 Adrenal Insufficiency Cyp11a1 alcoholic hepatitis Sts , Sult1e1 Alzheimer's disease Cyp19a1 , Hsd17b3 , Hsd3b1 , Hsd3b2 amenorrhea Cyp17a1 , Cyp19a1 , Por Antley-Bixler syndrome Por Antley-Bixler syndrome with disordered steroidogenesis Por aromatase excess syndrome Cyp19a1 Arterial Occlusive Diseases Fdxr attention deficit hyperactivity disorder Sts Auditory Neuropathy Fdxr autism spectrum disorder Cyp11a1 , Cyp19a1 , Hsd17b1 , Hsd3b1 , Sts autistic disorder Cyp19a1 bladder neck obstruction Cyp19a1 bone resorption disease Cyp19a1 Brain Injuries Cyp11a1 breast cancer Cyp17a1 , Cyp19a1 , Sult1e1 Breast Neoplasms Cyp17a1 , Cyp19a1 Cardiomegaly Cyp11a1 , Star Chemical and Drug Induced Liver Injury Sult1e1 cholelithiasis Cyp17a1 chronic obstructive pulmonary disease Cyp11a1 congenital adrenal hyperplasia Cyp11a1 , Cyp17a1 , Hsd3b2 , Por , Star Congenital Adrenal Hyperplasia due to 21 Hydroxylase Deficiency Cyp11a1 , Cyp17a1 , Por Congenital Adrenal Hyperplasia, Type 5 Cyp17a1 congenital adrenal insufficiency Cyp11a1 congestive heart failure Por COVID-19 Sts Critical Illness Cyp19a1 cryptorchidism Hsd3b2 , Sts cytochrome P450 oxidoreductase deficiency Por Desbuquois dysplasia Por Diabetic Nephropathies Cyp19a1 disorder of sexual development Hsd17b3 , Por Disorders of Environmental Origin Cyp11a1 , Star endometrial cancer Cyp19a1 , Sult1e1 Endometrial Neoplasms Cyp11a1 , Hsd17b2 , Star endometriosis Cyp19a1 , Hsd17b1 , Hsd17b2 Ependymomas Hsd3b2 Esophageal Neoplasms Cyp19a1 esophagus adenocarcinoma Cyp19a1 Experimental Diabetes Mellitus Cyp11a1 , Cyp19a1 , Star , Sts Experimental Liver Cirrhosis Cyp17a1 , Hsd17b2 , Sult1e1 , Sult2a1 Female Infertility Cyp17a1 , Cyp19a1 Fetal Growth Retardation Cyp11a1 , Star Fever Star Fibrosis Cyp19a1 Fine-Lubinsky Syndrome Por fundus dystrophy Fdxr gallbladder cancer Cyp17a1 genetic disease Cyp11a1 , Cyp17a1 , Fdxr , Hsd3b2 , Por , Star , Sts Genetic Predisposition to Disease Cyp17a1 gestational diabetes Cyp19a1 gliosarcoma Por hepatocellular carcinoma Cyp17a1 , Hsd3b2 Hirschsprung's disease Por hyperglycemia Cyp11a1 Hyperkalemia Cyp17a1 hyperprolactinemia Hsd3b1 , Hsd3b2 hypertension Cyp11a1 , Cyp19a1 , Hsd3b1 , Hsd3b2 , Sts hypogonadism Cyp11a1 , Cyp17a1 , Cyp19a1 , Hsd3b1 , Star hypopituitarism Cyp17a1 , Cyp19a1 hypospadias Hsd3b1 , Hsd3b2 Hypospadias 1, X-Linked Hsd3b2 Hypotension Por hypothyroidism Cyp19a1 , Hsd3b1 , Star Inflammation Sts Insulin Resistance Sts invasive ductal carcinoma Hsd17b1 Kidney Reperfusion Injury Cyp19a1 Knee Osteoarthritis Cyp19a1 learning disability Por Lipoid Congenital Adrenal Hyperplasia Cyp11a1 , Star liver disease Sult1e1 Lung Injury Por male infertility Cyp17a1 malignant hypertension Cyp17a1 metabolic dysfunction-associated steatotic liver disease Cyp17a1 Multiple mitochondrial dysfunctions syndrome 9A Fdxr Multiple mitochondrial dysfunctions syndrome 9B Fdxr Musculoskeletal Abnormalities Por Neoplasm Metastasis Cyp19a1 , Sult1e1 Neoplastic Cell Transformation Por nephrosis Cyp11a1 , Star neural tube defect Por Neuralgia Cyp17a1 obesity Sts Oligomenorrhea Cyp17a1 optic atrophy Fdxr OPTIC ATROPHY-ATAXIA-PERIPHERAL NEUROPATHY-GLOBAL DEVELOPMENTAL DELAY SYNDROME Fdxr osteoporosis Cyp17a1 , Cyp19a1 ovarian cancer Cyp19a1 ovarian cyst Cyp17a1 ovarian disease Cyp19a1 pancreatic cancer Cyp17a1 pancreatitis Fdx1 Paranoid Disorders Hsd3b2 placental insufficiency Cyp19a1 polycystic ovary syndrome Cyp17a1 , Cyp19a1 , Hsd3b1 , Hsd3b2 , Star Postmenopausal Osteoporosis Cyp19a1 primary ovarian insufficiency Cyp17a1 , Por prostate cancer Cyp17a1 , Sult2a1 prostate carcinoma in situ Cyp19a1 Prostatic Neoplasms Cyp17a1 , Cyp19a1 , Hsd17b1 , Hsd17b3 , Hsd3b1 , Hsd3b2 , Sult1e1 , Sult2a1 prostatitis Cyp19a1 protein-energy malnutrition Cyp19a1 Recurrence Cyp19a1 Reperfusion Injury Cyp19a1 , Sult1e1 rheumatoid arthritis Sts sciatic neuropathy Cyp11a1 , Cyp17a1 , Hsd3b1 sexual health disorder Cyp17a1 Sexual Infantilism Cyp19a1 Sjogren's syndrome Cyp19a1 Spontaneous Abortions Hsd17b1 status epilepticus Cyp11a1 steatotic liver disease Cyp19a1 , Sts syndactyly-telecanthus-anogenital and renal malformations syndrome Star Tissue Adhesions Cyp19a1 type 2 diabetes mellitus Cyp11a1 , Hsd17b3 , Hsd3b1 , Star urethral obstruction Cyp19a1 urinary bladder cancer Cyp17a1 , Cyp19a1 , Por Weight Gain Sts X-linked ichthyosis Sts